BetterHelp vs Moderna
Side-by-side comparison of AI visibility scores, market position, and capabilities
World's largest online therapy platform, 30,000+ licensed therapists, Sunnyvale CA, owned by Teladoc Health. Consumer-focused text, phone, and video therapy.
About
BetterHelp is a Sunnyvale, California-based online therapy platform founded in 2013 and acquired by Teladoc Health in 2015. The platform is the world's largest online therapy service, with more than 30,000 licensed therapists and counselors available to members across the United States and internationally. BetterHelp is a direct-to-consumer service, allowing individuals to sign up, complete a brief matching questionnaire, and be paired with a therapist within days.\n\nMembers communicate with their therapist through multiple formats including text messaging, live chat, phone calls, and video sessions, offering a level of flexibility and asynchronous access that traditional therapy cannot match. Subscriptions are priced on a weekly or monthly basis with financial assistance available for lower-income members. BetterHelp has heavily invested in consumer brand awareness through podcast advertising and influencer partnerships, making it one of the most recognized names in consumer mental health.\n\nBetterHelp operates as part of Teladoc Health's mental health division alongside Teladoc's other behavioral health offerings, and the parent company's scale provides infrastructure and insurance relationship advantages. Despite facing regulatory scrutiny and advertiser criticism around messaging practices in 2022–2023, BetterHelp remains the dominant player in direct-to-consumer online therapy by volume of active clients and therapist network size.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.